AMERI Holdings is Now Enveric Biosciences
Hit enter to search or ESC to close
Enveric Biosciences
  • About
    • Company Overview
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
    • Collaborations
  • Science
    • CBD Combination Therapies
    • Intellectual Property
  • Pipeline
    • Development Programs
    • Enabling Partnership with Tikun Olam
    • Glioblastoma Multiforme
    • Radiation Dermatitis
    • Chemotherapy-Induced Peripheral Neuropathy
    • Additional Development Programs
  • News & Media
  • Investors
    • Investor Overview
    • Press Releases
    • Events + Presentations
    • Company Information
    • SEC Filings
    • Stock Information
    • Corporate Governance
    • News Alerts
  • Contact
    • General Inquiries
    • Career Opportunities
    • Partnership Inquiries
Feb 04 2021
Love0

Jazz Leaps into Epilepsy with $7.2B Buyout of Cannabinoid Drugmaker GW Pharma [Fierce pharma]

https://www.fiercepharma.com/pharma/jazz-eyes-epilepsy-market-7-2b-buyout-cannabinoid-drugmaker-gw
Feb 04 2021
Love0

Cannabis Stocks Rally Anew as $7 Billion GW Pharma Deal Spurs Interest in Weed and its Medical Benefits [MarketWatch]

https://www.marketwatch.com/story/cannabis-stocks-rally-anew-as-7-billion-gw-pharma-deal-spurs-interest-in-weed-and-its-medical-benefits-11612376529
Apr 05 2019
Love0

Medical cannabinoids (CBD) and brain tumours – Interview with Dr. Wai Liu (via Brain Tumour Research)

https://www.braintumourresearch.org/media/our-blog/blog-item/our-blog/2019/04/05/medical-cannabinoids-(cbd)-and-brain-tumours---interview-with-dr-wai-liu
Feb 19 2019
Love0

Cannabis Executives Reveal The Industry’s 2019 Challenges And A Few Opportunities Too

https://www.forbes.com/sites/julieweed/2019/02/19/cannabis-executives-reveal-the-industrys-2019-challenges-and-a-few-opportunities-too/

Sign Up for Updates

© 2021 Enveric Biosciences | Terms of Use | Privacy Policy
Enveric Biosciences is a development stage company that markets no products at this time. The content of this site is not intended to be promotional or to suggest any product or use of a product that has been approved by any regulatory body.

  • About
    • Company Overview
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
    • Collaborations
  • Science
    • CBD Combination Therapies
    • Intellectual Property
  • Pipeline
    • Development Programs
    • Enabling Partnership with Tikun Olam
    • Glioblastoma Multiforme
    • Radiation Dermatitis
    • Chemotherapy-Induced Peripheral Neuropathy
    • Additional Development Programs
  • News & Media
  • Investors
    • Investor Overview
    • Press Releases
    • Events + Presentations
    • Company Information
    • SEC Filings
    • Stock Information
    • Corporate Governance
    • News Alerts
  • Contact
    • General Inquiries
    • Career Opportunities
    • Partnership Inquiries